表紙
市場調查報告書

全球難治性角膜表皮缺損治療市場:至2027年的產業趨勢及預測

Global Persistent Corneal Epithelial Defects Treatment Market - Industry Trends and Forecast to 2027

出版商 Data Bridge Market Research Private Limited 商品編碼 919235
出版日期 內容資訊 英文 344 Pages
商品交期: 最快1-2個工作天內
價格
全球難治性角膜表皮缺損治療市場:至2027年的產業趨勢及預測 Global Persistent Corneal Epithelial Defects Treatment Market - Industry Trends and Forecast to 2027
出版日期: 2019年11月01日內容資訊: 英文 344 Pages
簡介

全球難治性角膜表皮缺損治療市場在2020年∼2027年間,預測將以4.5%的年複合成長率成長。

本報告提供全球全球難治性角膜表皮缺損治療市場的相關調查,市場機會和課題,成長阻礙因素,各臨床性原因、類型、終端用戶、流通管道、地區的市場分析,競爭情形,主要企業的簡介等資訊。

第1章 簡介

  • 調查的目的
  • 市場定義
  • 市場概要
  • 限制事項
  • 對象市場

第2章 市場區隔

  • 對象市場
  • 地理範圍
  • 調查考慮年份
  • 貨幣、價格
  • DBMR的TRIPOD資料檢驗模式
  • 多變量建模
  • 產品生命線曲線
  • 主要意見領袖的主要會談
  • DBMR的市場地位電網
  • 廠商市場佔有率分析
  • 第二手資料
  • 前提條件

第3章 摘要整理

第4章 市場概況

  • 成長要素
    • 難治性角膜表皮缺損及其他相關的併發症的增加
    • 眼睛手術的病例增加及隱形眼鏡的使用
    • 成為PCED的高齡化人口增加
    • 機械性外傷的增加
  • 阻礙因素
    • 嚴格的法規手續
    • 為了治療PCED的潛在的醫療需求
    • 持續性的角膜表皮缺損治療的高成本
  • 市場機會
    • 新治療藥的開發
    • 疾病診斷和治療相關意識的提高
    • 市場參與企業的策略性舉措
    • 新興市場經濟重要的機會創造
  • 課題
    • 第三方供應商的依賴關係

第5章 重要的洞察

第6章 流行病學

第7章 市場分析:各臨床性原因

  • 概要
  • 發炎性疾病
  • 神經營養性角膜炎(NK)
  • 表皮/邊緣幹細胞缺損
  • 其他

第8章 市場分析:各類型

  • 概要
  • 設備
    • 治療性隱形眼鏡
    • 羊膜薄膜
    • 淚點塞
    • 角膜移植
  • 醫藥品
    • 藥物的種類
    • 給藥途徑

第9章 市場分析:各終端用戶

  • 概要
  • 醫院
  • 居家護理
  • 專門診所
  • 其他

第10章 市場分析:流通管道

  • 概要
  • 醫院藥局
  • 零售藥局
  • 線上藥局

第11章 市場分析:各地區

  • 概要
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 荷蘭
    • 瑞士
    • 比利時
    • 土耳其
    • 奧地利
    • 愛爾蘭
    • 挪威
    • 匈牙利
    • 波蘭
    • 立陶宛
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 新加坡
    • 泰國
    • 馬來西亞
    • 印尼
    • 菲律賓
    • 越南
    • 亞太地區
  • 南美
    • 巴西
    • 阿根廷
    • 秘魯
    • 其他
  • 中東、非洲
    • 阿拉伯聯合大公國
    • 沙烏地阿拉伯
    • 南非
    • 以色列
    • 科威特
    • 埃及
    • 其他

第12章 競爭情形

  • 企業佔有率分析:全球
  • 企業佔有率分析:北美
  • 企業佔有率分析:歐洲
  • 企業佔有率分析:亞太地區

第13章 企業簡介

  • JOHNSON & JOHNSON SERVICES, INC.
    • 企業概要
    • 收益分析
    • 企業的佔有率分析
    • 產品系列
    • 最近的開發
  • ALLERGAN
  • BIO-TISSUE(TISSUETECH, INC旗下)
  • LABORATOIRES THEA SAS
  • NOVARTIS AG
  • BAUSCH HEALTH
  • INTEGRA LIFESCIENCES CORPORATION
  • ALMIRALL, S.A
  • DOMPE FARMACEUTICI SPA
  • HUNT VALLEY PHARMALAB
  • I-MED PHARMA INC.
  • KALA PHARMACEUTICALS
  • KATENA PRODUCTS. INC.
  • NEXT BIOSCIENCES
  • OCULAR SCIENCE, INC.
  • SKYE BIOLOGICS INC.

第14章 問卷調查

第15章 相關報告

目錄

Global persistent corneal epithelial defects treatment market is projected to register a CAGR of 4.5% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.

Market Segmentation

Global persistent corneal epithelial defects treatment market By Clinical Causes (Inflammatory Disease, Neurotrophic Keratitis (NK), Epithelial/Limbal Stem Cell Deficiency, Others), Type (Devices, Medication), End User (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Region (U.S., Canada and Mexico in North America, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Hungary, Lithuania, Austria, Ireland, Norway, Poland and Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific in the Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, South Africa, Rest of Middle East and Africa as a part of Middle East and Africa, Brazil, Argentina and Rest of South America as part of South America) Market Trends and Forecast to 2027.

Some of the major factors contributing to the growth of the market are:

  • Increasing prevalence of persistent corneal epithelial defects and other related complications.
  • Rising cases of eye surgeries and usage of contact lenses.

Key Market Players

The key market players for global persistent corneal epithelial defects treatment market are listed below:

  • Dompe Farmaceutici S.p.A
  • Novartis AG
  • Allergan
  • Next Biosciences
  • Katena Products. Inc.
  • Johnson & Johnson Services, Inc.
  • Hunt Valley PharmaLAB
  • Laboratoires THEA S.A.S
  • Skye Biologics Inc.
  • I-MED Pharma inc.
  • Almirall, S.A
  • Ocular Science, Inc.
  • Kala Pharmaceuticals
  • Bausch Health
  • Integra LifeSciences Corporation
  • BioTissue (A Subsidiary of TissueTech, Inc.)

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET
  • 1.4 LIMITATIONS
  • 1.5 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 CURRENCY AND PRICING
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.6 MULTIVARIATE MODELLING
  • 2.7 PRODUCTS LIFELINE CURVE
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.9 DBMR MARKET POSITION GRID
  • 2.10 VENDOR SHARE ANALYSIS
  • 2.11 SECONDARY SOURCES
  • 2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 MARKET OVERVIEW

  • 4.1 DRIVERS
    • 4.1.1 INCREASING PREVALENCE OF PERSISTENT CORNEAL EPITHELIAL DEFECTS AND OTHER RELATED COMPLICATIONS
    • 4.1.2 RISING CASES OF EYE SURGERIES AND USAGE OF CONTACT LENSES
    • 4.1.3 GROWING AGEING POPULATION AUGMENTING TOWARDS THE PCED CONDITION
    • 4.1.4 INCREASE IN MECHANICAL TRAUMAS CASES
  • 4.2 RESTRAINT
    • 4.2.1 STRINGENT REGULATORY PROCEDURES
    • 4.2.2 UNMET MEDICAL NEEDS FOR THE TREATMENT OF PCED
    • 4.2.3 HIGH COST OF PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENTS
  • 4.3 OPPORTUNITIES
    • 4.3.1 DEVELOPMENT OF NOVEL THERAPEUTICS
    • 4.3.2 INCREASING AWARENESS ABOUT DIAGNOSIS AND TREATMENT OF THE DISEASE
    • 4.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS
    • 4.3.4 EMERGING MARKET ECONOMY CREATES SIGNIFICANT OPPORTUNITIES
  • 4.4 CHALLENGES
    • 4.4.1 DEPENDENCY ON THIRD PARTY SUPPLIERS

5 PREMIUM INSIGHTS

6 EPIDEMIOLOGY

7 GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET,

BY CLINICAL CAUSES 81

  • 7.1 OVERVIEW
  • 7.2 INFLAMMATORY DISEASE
  • 7.3 NEUROTROPHIC KERATITIS (NK)
  • 7.4 EPITHELIAL/LIMBAL STEM CELL DEFICIENCY
  • 7.5 OTHERS

8 GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET,

BY TYPE 88

  • 8.1 OVERVIEW
  • 8.2 DEVICES
    • 8.2.1 BANDAGE CONTACT LENS
    • 8.2.2 AMNIOTIC MEMBRANE GRAFTS
    • 8.2.3 PUNCTAL PLUGS
      • 8.2.3.1 SILICONE PLUG
      • 8.2.3.2 COLLAGEN PLUGS
    • 8.2.4 CORNEAL TRANSPLANTS
      • 8.2.4.1 KERATOPLASTY
      • 8.2.4.2 KERATOPROSTHESIS
  • 8.3 MEDICATION
    • 8.3.1 DRUG TYPE
      • 8.3.1.1 LUBRICANTS
      • 8.3.1.2 PROPHYLACTIC TOPICAL ANTIBIOTICS
        • 8.3.1.2.1 POLYMIXIN B-TRIMETHOPRIM + FLUOROQUINOLONE
        • 8.3.1.2.2 FLUOROQUINOLONE
      • 8.3.1.3 TOPICAL OPHTHALMIC STEROIDS
      • 8.3.1.4 AUTOLOGOUS SERUM TEARS/AUTOLOGOUS SERUM EYE DROPS
      • 8.3.1.5 TETRACYCLINES
      • 8.3.1.6 HUMAN NERVE GROWTH FACTOR (OXERVATE)
      • 8.3.1.7 WOUND HEALING AGENTS
      • 8.3.1.8 OTHERS
    • 8.3.2 ROUTE OF ADMINISTRATION
      • 8.3.2.1 TOPICAL
      • 8.3.2.2 ORAL

9 GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET,

BY END USER 99

  • 9.1 OVERVIEW
  • 9.2 HOSPITALS
  • 9.3 HOMECARE
  • 9.4 SPECIALTY CLINICS
  • 9.5 OTHERS

10 GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET,

BY DISTRIBUTION CHANNEL 106

  • 10.1 OVERVIEW
  • 10.2 HOSPITAL PHARMACIES
  • 10.3 RETAIL PHARMACIES
  • 10.4 ONLINE PHARMACIES

11 GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET,

BY GEOGRAPHY 113

  • 11.1 OVERVIEW
  • 11.2 NORTH AMERICA
    • 11.2.1 U.S.
    • 11.2.2 CANADA
    • 11.2.3 MEXICO
  • 11.3 EUROPE
    • 11.3.1 GERMANY
    • 11.3.2 U.K.
    • 11.3.3 FRANCE
    • 11.3.4 ITALY
    • 11.3.5 SPAIN
    • 11.3.6 RUSSIA
    • 11.3.7 NETHERLANDS
    • 11.3.8 SWITZERLAND
    • 11.3.9 BELGIUM
    • 11.3.10 TURKEY
    • 11.3.11 AUSTRIA
    • 11.3.12 IRELAND
    • 11.3.13 NORWAY
    • 11.3.14 HUNGARY
    • 11.3.15 POLAND
    • 11.3.16 LITHUANIA
    • 11.3.17 REST OF EUROPE
  • 11.4 ASIA-PACIFIC
    • 11.4.1 JAPAN
    • 11.4.2 CHINA
    • 11.4.3 INDIA
    • 11.4.4 SOUTH KOREA
    • 11.4.5 AUSTRALIA
    • 11.4.6 SINGAPORE
    • 11.4.7 THAILAND
    • 11.4.8 MALAYSIA
    • 11.4.9 INDONESIA
    • 11.4.10 PHILIPPINES
    • 11.4.11 VIETNAM
    • 11.4.12 REST OF ASIA-PACIFIC
  • 11.5 SOUTH AMERICA
    • 11.5.1 BRAZIL
    • 11.5.2 ARGENTINA
    • 11.5.3 PERU
    • 11.5.4 REST OF SOUTH AMERICA
  • 11.6 MIDDLE EAST AND AFRICA
    • 11.6.1 UAE
    • 11.6.2 SAUDI ARABIA
    • 11.6.3 SOUTH AFRICA
    • 11.6.4 ISRAEL
    • 11.6.5 KUWAIT
    • 11.6.6 EGYPT
    • 11.6.7 REST OF MIDDLE EAST AND AFRICA

12 GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, COMPANY LANDSCAPE

  • 12.1 COMPANY SHARE ANALYSIS: GLOBAL
  • 12.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
  • 12.3 COMPANY SHARE ANALYSIS: EUROPE
  • 12.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

13 COMPANY PROFILE

  • 13.1 JOHNSON & JOHNSON SERVICES, INC.
    • 13.1.1 COMPANY SNAPSHOT
    • 13.1.2 REVENUE ANALYSIS
    • 13.1.3 COMPANY SHARE ANALYSIS
    • 13.1.4 PRODUCT PORTFOLIO
    • 13.1.5 RECENT DEVELOPMENTS
  • 13.2 ALLERGAN
    • 13.2.1 COMPANY SNAPSHOT
    • 13.2.2 REVENUE ANALYSIS
    • 13.2.3 COMPANY SHARE ANALYSIS
    • 13.2.4 PRODUCT PORTFOLIO
    • 13.2.5 RECENT DEVELOPMENT
  • 13.3 BIO-TISSUE (A SUBSIDIARY OF TISSUETECH, INC.)
    • 13.3.1 COMPANY SNAPSHOT
    • 13.3.2 COMPANY SHARE ANALYSIS
    • 13.3.3 PRODUCT PORTFOLIO
    • 13.3.4 RECENT DEVELOPMENTS
  • 13.4 LABORATOIRES THEA S.A.S
    • 13.4.1 COMPANY SNAPSHOT
    • 13.4.2 COMPANY SHARE ANALYSIS
    • 13.4.3 PRODUCT PORTFOLIO
    • 13.4.4 RECENT DEVELOPMENT
  • 13.5 NOVARTIS AG
    • 13.5.1 COMPANY SNAPSHOT
    • 13.5.2 REVENUE ANALYSIS
    • 13.5.3 PRODUCT PORTFOLIO
    • 13.5.4 RECENT DEVELOPMENT
  • 13.6 BAUSCH HEALTH
    • 13.6.1 COMPANY SNAPSHOT
    • 13.6.2 REVENUE ANALYSIS
    • 13.6.3 PRODUCT PORTFOLIO
    • 13.6.4 RECENT DEVELOPMENT
  • 13.7 INTEGRA LIFESCIENCES CORPORATION
    • 13.7.1 COMPANY SNAPSHOT
    • 13.7.2 REVENUE ANALYSIS
    • 13.7.3 PRODUCT PORTFOLIO
    • 13.7.4 RECENT DEVELOPMENT

  • 13.8 ALMIRALL, S.A
    • 13.8.1 COMPANY SNAPSHOT
    • 13.8.2 REVENUE ANALYSIS
    • 13.8.3 PRODUCT PORTFOLIO
    • 13.8.4 RECENT DEVELOPMENT
  • 13.9 DOMPE FARMACEUTICI S.P.A.
    • 13.9.1 COMPANY SNAPSHOT
    • 13.9.2 PRODUCT PORTFOLIO
    • 13.9.3 RECENT DEVELOPMENTS
  • 13.10 HUNT VALLEY PHARMALAB
    • 13.10.1 COMPANY SNAPSHOT
    • 13.10.2 PRODUCT PORTFOLIO
    • 13.10.3 RECENT DEVELOPMENT
  • 13.11 I-MED PHARMA INC.
    • 13.11.1 COMPANY SNAPSHOT
    • 13.11.2 PRODUCT PORTFOLIO
    • 13.11.3 RECENT DEVELOPMENT
  • 13.12 KALA PHARMACEUTICALS
    • 13.12.1 COMPANY SNAPSHOT
    • 13.12.2 PRODUCT PORTFOLIO
    • 13.12.3 RECENT DEVELOPMENTS
  • 13.13 KATENA PRODUCTS. INC.
    • 13.13.1 COMPANY SNAPSHOT
    • 13.13.2 PRODUCT PORTFOLIO
    • 13.13.3 RECENT DEVELOPMENTS
  • 13.14 NEXT BIOSCIENCES
    • 13.14.1 COMPANY SNAPSHOT
    • 13.14.2 PRODUCT PORTFOLIO
    • 13.14.3 RECENT DEVELOPMENT
  • 13.15 OCULAR SCIENCE, INC.
    • 13.15.1 COMPANY SNAPSHOT
    • 13.15.2 PRODUCT PORTFOLIO
    • 13.15.3 RECENT DEVELOPMENT
  • 13.16 SKYE BIOLOGICS INC.
    • 13.16.1 COMPANY SNAPSHOT
    • 13.16.2 PRODUCT PORTFOLIO
    • 13.16.3 RECENT DEVELOPMENT

14 QUESTIONNAIRE

15 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 2 GLOBAL INFLAMMATORY DISEASE IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 3 GLOBAL NEUROTROPHIC KERATITIS (NK) IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 4 GLOBAL EPITHELIAL/LIMBAL STEM CELL DEFICIENCY IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 5 GLOBAL OTHERS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 6 GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 7 GLOBAL DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 8 GLOBAL DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 9 GLOBAL DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 10 GLOBAL PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 11 GLOBAL CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 12 GLOBAL MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 13 GLOBAL MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 14 GLOBAL PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 15 GLOBAL MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 16 GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 17 GLOBAL HOSPITALS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 18 GLOBAL HOMECARE IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 19 GLOBAL SPECIALTY CLINICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 20 GLOBAL OTHERS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 21 GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 22 GLOBAL HOSPITAL PHARMACIES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 23 GLOBAL RETAIL PHARMACIES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 24 GLOBAL ONLINE PHARMACIES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 25 GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY GEOGRAPHY, 2018-2027 (USD MILLION)
  • TABLE 26 NORTH AMERICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 27 NORTH AMERICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 28 NORTH AMERICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 29 NORTH AMERICA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 30 NORTH AMERICA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 31 NORTH AMERICA PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 32 NORTH AMERICA CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 33 NORTH AMERICA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 34 NORTH AMERICA PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 35 NORTH AMERICA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 36 NORTH AMERICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 37 NORTH AMERICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 38 U.S. PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 39 U.S. PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 40 U.S. DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 41 U.S. DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 42 U.S. PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 43 U.S. CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 44 U.S. MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 45 U.S. PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 46 U.S. MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 47 U.S. PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 48 U.S. PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 49 CANADA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 50 CANADA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 51 CANADA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 52 CANADA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 53 CANADA PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 54 CANADA CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 55 CANADA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 56 CANADA PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 57 CANADA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 58 CANADA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 59 CANADA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 60 MEXICO PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 61 MEXICO PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 62 MEXICO DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 63 MEXICO DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 64 MEXICO PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 65 MEXICO CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 66 MEXICO MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 67 MEXICO PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 68 MEXICO MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 69 MEXICO PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 70 MEXICO PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 71 EUROPE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY COUNTRY 2018-2027 (USD MILLION)
  • TABLE 72 EUROPE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 73 EUROPE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 74 EUROPE DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 75 EUROPE DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 76 EUROPE PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 77 EUROPE CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 78 EUROPE MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 79 EUROPE PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 80 EUROPE MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 81 EUROPE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 82 EUROPE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 83 GERMANY PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 84 GERMANY PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 85 GERMANY DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 86 GERMANY DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 87 GERMANY PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 88 GERMANY CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 89 GERMANY MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 90 GERMANY PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 91 GERMANY MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 92 GERMANY PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 93 GERMANY PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 94 U.K. PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 95 U.K. PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 96 U.K. DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 97 U.K. DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 98 U.K. PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 99 U.K. CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 100 U.K. MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 101 U.K. PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 102 U.K. MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 103 U.K. PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 104 U.K. PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 105 FRANCE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 106 FRANCE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 107 FRANCE DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 108 FRANCE DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 109 FRANCE PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 110 FRANCE CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 111 FRANCE MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 112 FRANCE PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 113 FRANCE MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 114 FRANCE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 115 FRANCE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 116 ITALY PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 117 ITALY PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 118 ITALY DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 119 ITALY DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 120 ITALY PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 121 ITALY CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 122 ITALY MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 123 ITALY PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 124 ITALY MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 125 ITALY PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 126 ITALY PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 127 SPAIN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 128 SPAIN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 129 SPAIN DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 130 SPAIN DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 131 SPAIN PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 132 SPAIN CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 133 SPAIN MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 134 SPAIN PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 135 SPAIN MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 136 SPAIN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 137 SPAIN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 138 RUSSIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 139 RUSSIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 140 RUSSIA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 141 RUSSIA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 142 RUSSIA PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 143 RUSSIA CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 144 RUSSIA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 145 RUSSIA PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 146 RUSSIA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 147 RUSSIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 148 RUSSIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 149 NETHERLANDS PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 150 NETHERLANDS PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 151 NETHERLANDS DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 152 NETHERLANDS DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 153 NETHERLANDS PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 154 NETHERLANDS CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 155 NETHERLANDS MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 156 NETHERLANDS PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 157 NETHERLANDS MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 158 NETHERLANDS PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 159 NETHERLANDS PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 160 SWITZERLAND PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 161 SWITZERLAND PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 162 SWITZERLAND DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 163 SWITZERLAND DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 164 SWITZERLAND PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 165 SWITZERLAND CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 166 SWITZERLAND MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 167 SWITZERLAND PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 168 SWITZERLAND MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 169 SWITZERLAND PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 170 SWITZERLAND PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 171 BELGIUM PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 172 BELGIUM PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 173 BELGIUM DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 174 BELGIUM DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 175 BELGIUM PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 176 BELGIUM CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 177 BELGIUM MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 178 BELGIUM PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 179 BELGIUM MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 180 BELGIUM PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 181 BELGIUM PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 182 TURKEY PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 183 TURKEY PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 184 TURKEY DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 185 TURKEY DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 186 TURKEY PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 187 TURKEY CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 188 TURKEY MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 189 TURKEY PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 190 TURKEY MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 191 TURKEY PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 192 TURKEY PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 193 AUSTRIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 194 AUSTRIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 195 AUSTRIA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 196 AUSTRIA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 197 AUSTRIA PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 198 AUSTRIA CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 199 AUSTRIA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 200 AUSTRIA PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 201 AUSTRIA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 202 AUSTRIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 203 AUSTRIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 204 IRELAND PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 205 IRELAND PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 206 IRELAND DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 207 IRELAND DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 208 IRELAND PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 209 IRELAND CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 210 IRELAND MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 211 IRELAND PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 212 IRELAND MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 213 IRELAND PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 214 IRELAND PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 215 NORWAY PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 216 NORWAY PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 217 NORWAY DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 218 NORWAY DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 219 NORWAY PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 220 NORWAY CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 221 NORWAY MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 222 NORWAY PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 223 NORWAY MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 224 NORWAY PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 225 NORWAY PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 226 HUNGARY PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 227 HUNGARY PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 228 HUNGARY DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 229 HUNGARY DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 230 HUNGARY PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 231 HUNGARY CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 232 HUNGARY MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 233 HUNGARY PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 234 HUNGARY MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 235 HUNGARY PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 236 HUNGARY PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 237 POLAND PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 238 POLAND PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 239 POLAND DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 240 POLAND DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 241 POLAND PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 242 POLAND CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 243 POLAND MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 244 POLAND PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 245 POLAND MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 246 POLAND PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 247 POLAND PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 248 LITHUANIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 249 LITHUANIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 250 LITHUANIA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 251 LITHUANIA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 252 LITHUANIA PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 253 LITHUANIA CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 254 LITHUANIA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 255 LITHUANIA PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 256 LITHUANIA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 257 LITHUANIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 258 LITHUANIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 259 REST OF EUROPE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 260 ASIA-PACIFIC PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 261 ASIA-PACIFIC PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 262 ASIA-PACIFIC PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 263 ASIA-PACIFIC DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 264 ASIA-PACIFIC DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 265 ASIA-PACIFIC PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 266 ASIA-PACIFIC CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 267 ASIA-PACIFIC MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 268 ASIA-PACIFIC PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 269 ASIA-PACIFIC MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 270 ASIA-PACIFIC PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 271 ASIA-PACIFIC PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 272 JAPAN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 273 JAPAN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 274 JAPAN DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 275 JAPAN DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 276 JAPAN PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 277 JAPAN CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 278 JAPAN MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 279 JAPAN PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 280 JAPAN MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 281 JAPAN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 282 JAPAN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 283 CHINA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 284 CHINA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 285 CHINA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 286 CHINA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 287 CHINA PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 288 CHINA CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 289 CHINA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 290 CHINA PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 291 CHINA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 292 CHINA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 293 CHINA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 294 INDIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 295 INDIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 296 INDIA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 297 INDIA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 298 INDIA PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 299 INDIA CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 300 INDIA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 301 INDIA PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 302 INDIA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 303 INDIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 304 INDIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 305 SOUTH KOREA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 306 SOUTH KOREA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 307 SOUTH KOREA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 308 SOUTH KOREA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 309 SOUTH KOREA PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 310 SOUTH KOREA CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 311 SOUTH KOREA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 312 SOUTH KOREA PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 313 SOUTH KOREA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 314 SOUTH KOREA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 315 SOUTH KOREA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 316 AUSTRALIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 317 AUSTRALIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 318 AUSTRALIA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 319 AUSTRALIA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 320 AUSTRALIA PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 321 AUSTRALIA CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 322 AUSTRALIA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 323 AUSTRALIA PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 324 AUSTRALIA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 325 AUSTRALIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 326 AUSTRALIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 327 SINGAPORE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 328 SINGAPORE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 329 SINGAPORE DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 330 SINGAPORE DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 331 SINGAPORE PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 332 SINGAPORE CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 333 SINGAPORE MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 334 SINGAPORE PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 335 SINGAPORE MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 336 SINGAPORE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 337 SINGAPORE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 338 THAILAND PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 339 THAILAND PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 340 THAILAND DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 341 THAILAND DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 342 THAILAND PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 343 THAILAND CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 344 THAILAND MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 345 THAILAND PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 346 THAILAND MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 347 THAILAND PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 348 THAILAND PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 349 MALAYSIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 350 MALAYSIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 351 MALAYSIA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 352 MALAYSIA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 353 MALAYSIA PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 354 MALAYSIA CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 355 MALAYSIA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 356 MALAYSIA PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 357 MALAYSIA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 358 MALAYSIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 359 MALAYSIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 360 INDONESIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 361 INDONESIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 362 INDONESIA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 363 INDONESIA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 364 INDONESIA PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 365 INDONESIA CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 366 INDONESIA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 367 INDONESIA PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 368 INDONESIA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 369 INDONESIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 370 INDONESIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 371 PHILIPPINES PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 372 PHILIPPINES PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 373 PHILIPPINES DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 374 PHILIPPINES DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 375 PHILIPPINES PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 376 PHILIPPINES CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 377 PHILIPPINES MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 378 PHILIPPINES PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 379 PHILIPPINES MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 380 PHILIPPINES PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 381 PHILIPPINES PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 382 VIETNAM PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 383 VIETNAM PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 384 VIETNAM DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 385 VIETNAM DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 386 VIETNAM PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 387 VIETNAM CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 388 VIETNAM MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 389 VIETNAM PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 390 VIETNAM MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 391 VIETNAM PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 392 VIETNAM PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 393 REST OF ASIA-PACIFIC PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 394 SOUTH AMERICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY COUNTRY 2018-2027 (USD MILLION)
  • TABLE 395 SOUTH AMERICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 396 SOUTH AMERICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 397 SOUTH AMERICA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 398 SOUTH AMERICA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 399 SOUTH AMERICA PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 400 SOUTH AMERICA CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 401 SOUTH AMERICA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 402 SOUTH AMERICA PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 403 SOUTH AMERICA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 404 SOUTH AMERICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 405 SOUTH AMERICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 406 BRAZIL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 407 BRAZIL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 408 BRAZIL DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 409 BRAZIL DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 410 BRAZIL PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 411 BRAZIL CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 412 BRAZIL MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 413 BRAZIL PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 414 BRAZIL MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 415 BRAZIL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 416 BRAZIL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 417 ARGENTINA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 418 ARGENTINA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 419 ARGENTINA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 420 ARGENTINA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 421 ARGENTINA PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 422 ARGENTINA CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 423 ARGENTINA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 424 ARGENTINA PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 425 ARGENTINA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 426 ARGENTINA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 427 ARGENTINA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 428 PERU PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 429 PERU PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 430 PERU DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 431 PERU DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 432 PERU PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 433 PERU CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 434 PERU MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 435 PERU PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 436 PERU MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 437 PERU PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 438 PERU PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 439 REST OF SOUTH AMERICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 440 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY COUNTRY 2018-2027 (USD MILLION)
  • TABLE 441 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 442 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 443 MIDDLE EAST AND AFRICA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 444 MIDDLE EAST AND AFRICA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 445 MIDDLE EAST AND AFRICA PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 446 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 447 MIDDLE EAST AND AFRICA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 448 MIDDLE EAST AND AFRICA PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 449 MIDDLE EAST AND AFRICA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 450 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 451 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 452 UAE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 453 UAE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 454 UAE DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 455 UAE DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 456 UAE PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 457 UAE CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 458 UAE MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 459 UAE PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 460 UAE MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 461 UAE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 462 UAE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 463 SAUDI ARABIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 464 SAUDI ARABIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 465 SAUDI ARABIA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 466 SAUDI ARABIA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 467 SAUDI ARABIA PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 468 SAUDI ARABIA CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 469 SAUDI ARABIA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 470 SAUDI ARABIA PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 471 SAUDI ARABIA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 472 SAUDI ARABIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 473 SAUDI ARABIA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 474 SOUTH AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 475 SOUTH AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 476 SOUTH AFRICA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 477 SOUTH AFRICA DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 478 SOUTH AFRICA PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 479 SOUTH AFRICA CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 480 SOUTH AFRICA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 481 SOUTH AFRICA PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 482 SOUTH AFRICA MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 483 SOUTH AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 484 SOUTH AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 485 ISRAEL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 486 ISRAEL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 487 ISRAEL DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 488 ISRAEL DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 489 ISRAEL PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 490 ISRAEL CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 491 ISRAEL MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 492 ISRAEL PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 493 ISRAEL MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 494 ISRAEL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 495 ISRAEL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 496 KUWAIT PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 497 KUWAIT PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 498 KUWAIT DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 499 KUWAIT DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 500 KUWAIT PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 501 KUWAIT CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 502 KUWAIT MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 503 KUWAIT PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 504 KUWAIT MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 505 KUWAIT PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 506 KUWAIT PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 507 EGYPT PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • TABLE 508 EGYPT PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 509 EGYPT DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 510 EGYPT DEVICES IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 511 EGYPT PUNCTAL PLUGS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 512 EGYPT CORNEAL TRANSPLANTS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 513 EGYPT MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 514 EGYPT PROPHYLACTIC TOPICAL ANTIBIOTICS IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DRUG TYPE, 2018-2027 (USD MILLION)
  • TABLE 515 EGYPT MEDICATION IN PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
  • TABLE 516 EGYPT PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 517 EGYPT PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 518 REST OF MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: SEGMENTATION
  • FIGURE 2 GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: DATA TRIANGULATION
  • FIGURE 3 GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: DROC ANALYSIS
  • FIGURE 4 GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET : GLOBAL VS REGIONAL MARKET ANALYSIS
  • FIGURE 5 GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: COMPANY RESEARCH ANALYSIS
  • FIGURE 6 GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: INTERVIEW DEMOGRAPHICS
  • FIGURE 7 GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: DBMR MARKET POSITION GRID
  • FIGURE 8 GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: VENDOR SHARE ANALYSIS
  • FIGURE 9 GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: SEGMENTATION
  • FIGURE 10 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET AND EUROPE IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2020 TO 2027
  • FIGURE 11 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET
  • FIGURE 12 NUMBER OF EYELID SURGERY IN U.S. IN 2018
  • FIGURE 13 AGEING WORLD POPULATION (NUMBER OF PERSONS AGED 60 YEARS OR OLDER IN MILLIONS)
  • FIGURE 14 AGEING NORTH AMERICA POPULATION (IN MILLION)
  • FIGURE 15 AGEING EUROPE POPULATION (IN MILLION)
  • FIGURE 16 AGEING ASIA-PACIFIC POPULATION (IN MILLION)
  • FIGURE 17 GDP PER CAPITA 2010, 2017 AND 2025:
  • FIGURE 18 INCREASING PREVALENCE OF PERSISTENT CORNEAL EPITHELIAL DEFECTS AND OTHER RELATED COMPLICATIONS AND RISING CASES OF EYE SURGERIES AND USAGE OF CONTACT LENSES IS DRIVING GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET IN THE FORECAST PERIOD OF 2020 TO 2027
  • FIGURE 19 INFLAMMATORY DISEASE IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET IN 2020 & 2027
  • FIGURE 20 EUROPE IS THE FASTEST GROWING MARKET FOR PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MANUFACTURERS IN THE FORECAST PERIOD OF 2020 TO 2027
  • FIGURE 21 GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES (2019)
  • FIGURE 22 GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY CLINICAL CAUSES, 2018-2027 (USD MILLION)
  • FIGURE 23 GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY CLINICAL CAUSES, CAGR (2020-2027)
  • FIGURE 24 GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY CLINICAL CAUSES, LIFELINE CURVE
  • FIGURE 25 GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE (2019)
  • FIGURE 26 GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • FIGURE 27 GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY TYPE, CAGR (2020-2027)
  • FIGURE 28 GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY TYPE, LIFELINE CURVE
  • FIGURE 29 GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER (2019)
  • FIGURE 30 GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • FIGURE 31 GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY END USER, CAGR (2020-2027)
  • FIGURE 32 GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY END USER, LIFELINE CURVE
  • FIGURE 33 GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL (2019)
  • FIGURE 34 GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • FIGURE 35 GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2020-2027)
  • FIGURE 36 GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
  • FIGURE 37 GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: SNAPSHOT (2019)
  • FIGURE 38 GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY COUNTRY (2019)
  • FIGURE 39 GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 40 GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY COUNTRY (2019 & 2027)
  • FIGURE 41 GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY CLINICAL CAUSES (2020-2027)
  • FIGURE 42 NORTH AMERICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: SNAPSHOT (2019)
  • FIGURE 43 NORTH AMERICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY COUNTRY (2019)
  • FIGURE 44 NORTH AMERICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 45 NORTH AMERICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY COUNTRY (2019 & 2027)
  • FIGURE 46 NORTH AMERICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY CLINICAL CAUSES (2020-2027)
  • FIGURE 47 EUROPE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: SNAPSHOT (2019)
  • FIGURE 48 EUROPE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY COUNTRY (2019)
  • FIGURE 49 EUROPE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 50 EUROPE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY COUNTRY (2019 & 2027)
  • FIGURE 51 EUROPE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY CLINICAL CAUSES (2020-2027)
  • FIGURE 52 ASIA-PACIFIC PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: SNAPSHOT (2019)
  • FIGURE 53 ASIA-PACIFIC PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY COUNTRY (2019)
  • FIGURE 54 ASIA-PACIFIC PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 55 ASIA-PACIFIC PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY COUNTRY (2019 & 2027)
  • FIGURE 56 ASIA-PACIFIC PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY CLINICAL CAUSES (2020-2027)
  • FIGURE 57 SOUTH AMERICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: SNAPSHOT (2019)
  • FIGURE 58 SOUTH AMERICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY COUNTRY (2019)
  • FIGURE 59 SOUTH AMERICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 60 SOUTH AMERICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY COUNTRY (2019 & 2027)
  • FIGURE 61 SOUTH AMERICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY CLINICAL CAUSES (2020-2027)
  • FIGURE 62 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: SNAPSHOT (2019)
  • FIGURE 63 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY COUNTRY (2019)
  • FIGURE 64 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 65 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY COUNTRY (2019 & 2027)
  • FIGURE 66 MIDDLE EAST AND AFRICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: BY CLINICAL CAUSES (2020-2027)
  • FIGURE 67 GLOBAL PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 68 NORTH AMERICA PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 69 EUROPE PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 70 ASIA-PACIFIC PERSISTENT CORNEAL EPITHELIAL DEFECTS TREATMENT MARKET: COMPANY SHARE 2019 (%)